Found: 17
Select item for more details and to access through your institution.
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3123, doi. 10.1007/s00262-021-02871-1
- By:
- Publication type:
- Article
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2922, doi. 10.3390/cancers15112922
- By:
- Publication type:
- Article
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 409, doi. 10.3390/cancers15020409
- By:
- Publication type:
- Article
Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5694, doi. 10.3390/cancers14225694
- By:
- Publication type:
- Article
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5077, doi. 10.3390/cancers13205077
- By:
- Publication type:
- Article
Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4639, doi. 10.3390/cancers13184639
- By:
- Publication type:
- Article
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors †.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2826, doi. 10.3390/cancers13112826
- By:
- Publication type:
- Article
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 10, p. 1760, doi. 10.1002/ijc.34853
- By:
- Publication type:
- Article
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 12, p. 2493, doi. 10.1002/ijc.34479
- By:
- Publication type:
- Article
The unfavorable effects of COVID‐19 on Dutch advanced melanoma care.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 5, p. 816, doi. 10.1002/ijc.33833
- By:
- Publication type:
- Article
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 275, doi. 10.1007/s40801-022-00294-7
- By:
- Publication type:
- Article
Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220111
- By:
- Publication type:
- Article
Assessment of Simplified Methods for Quantification of <sup>18</sup>F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1221, doi. 10.2967/jnumed.118.220111
- By:
- Publication type:
- Article
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article